EUVIMEDEUVIMED entdecken
Crossref

Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry

Yi Zhou iD, Yaxin Zhang iD, Mingzhou Li iD, Tian Ming iD, Chao Zhang iD, Chengmei Huang iD, Jiexi Li iD, Fengtian Li iD, Huali Li iD, Enen Zhao iD, Feng Shu iD, Lingtao Liu iD und 6 weitere

Science Immunology · 2024

DOI: 10.1126/sciimmunol.ado8758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, 2024. Verfasst von Yi Zhou und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DEAD-box RNA Helicases, Proto-Oncogene Proteins p21(ras), RNA, Double-Stranded. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interferon (IFN) response is vital for the effectiveness of immune checkpoint inhibition (ICI) therapy. Our previous research showed that KRAS (Kirsten rat sarcoma viral) mutation impairs the IFN response in colorectal cancer (CRC), with an unclear mechanism. Here, we demonstrate that KRAS accelerates double-stranded RNA (dsRNA) degradation, impairing dsRNA sensing and IFN response by down-regulating DExD/H-box helicase 6 (DDX60). DDX60 was identified as a KRAS target here and could bind to dsRNAs to protect against RNA-induced silencing complex (RISC)–mediated degradation. Overexpressing DDX60 induced dsRNA accumulation, reactivated IFN signaling, and increased CRC sensitivity to ICI therapy. Mechanistically, KRAS engaged the AKT (also known as protein kinase B)–GSK3β (glycogen synthase kinase-3 beta) pathway to suppress STAT3 phosphorylation, thereby inhibiting STAT3-driven DDX60 transcription. Our findings reveal a role for KRAS in dsRNA homeostasis, suggesting potential strategies to convert “cold” tumors to “hot” and to overcome ICI resistance in CRC with KRAS mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDEAD-box RNA HelicasesProto-Oncogene Proteins p21(ras)RNA, Double-StrandedAnimalsFemaleHumansMiceCell Line, Tumor

Substanzen

DEAD-box RNA HelicasesKRAS protein, humanProto-Oncogene Proteins p21(ras)RNA, Double-StrandedDDX60 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
  • Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
  • Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

ORCID-Profile: Yi Zhou, Yaxin Zhang, Mingzhou Li, Tian Ming, Chao Zhang, Chengmei Huang, Jiexi Li, Fengtian Li, Huali Li, Enen Zhao, Feng Shu, Lingtao Liu, Xingyan Pan, Yijun Gao, Lin Tian, Libing Song, Huilin Huang, Wenting Liao

Zitieren

APA

Zhou, Y., Zhang, Y., Li, M., Ming, T., Zhang, C., Huang, C., Li, J., Li, F., Li, H., Zhao, E., Shu, F., Liu, L., Pan, X., Gao, Y., Tian, L., Song, L., Huang, H., & Liao, W. (2024). Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry. Science Immunology. https://doi.org/10.1126/sciimmunol.ado8758

Vancouver

Zhou Y, Zhang Y, Li M, Ming T, Zhang C, Huang C, et al. Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry. Science Immunology. 2024. doi:10.1126/sciimmunol.ado8758

BibTeX
@article{Zhou2024,
  author = {Zhou, Yi and Zhang, Yaxin and Li, Mingzhou and Ming, Tian and Zhang, Chao and Huang, Chengmei and Li, Jiexi and Li, Fengtian and Li, Huali and Zhao, Enen and Shu, Feng and Liu, Lingtao and Pan, Xingyan and Gao, Yijun and Tian, Lin and Song, Libing and Huang, Huilin and Liao, Wenting},
  title = {Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry},
  journal = {Science Immunology},
  year = {2024},
  doi = {10.1126/sciimmunol.ado8758}
}
Kostenlos starten →